Inhibition of P-type ATPases by [(dihydroindenyl)oxy]acetic acid (DIOA), a K+-Cl- cotransporter inhibitor

被引:18
作者
Fujii, Takuto
Ohira, Yuta
Itomi, Yasuo
Takahashi, Yuji
Asano, Shinji
Morii, Magotoshi
Takeguchi, Noriaki
Sakai, Hideki
机构
[1] Toyama Univ, Dept Pharmaceut Physiol, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan
[2] Ritsumeikan Univ, Dept Mol Physiol, Coll Informat Sci & Engn, Shiga 5258577, Japan
基金
日本学术振兴会;
关键词
DIOA ([(dihydroindenyl)oxy]acetic acid); K+-Cl- cotransporter; Na+; K+-ATPase; H+;
D O I
10.1016/j.ejphar.2006.12.031
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[(Dihydroindenyl)oxy] acetic acid (DIOA) has been used as a potent inhibitor of K+-Cl- cotransporter (IC50 = 10 mu M). Here we found that DIOA inhibited activities of P-type ATPases such as dog kidney Na+,K+-ATPase (IC50 = 53 mu M), hog gastric H+,K+-ATPase (IC50 = 97 mu M) and rabbit muscle Ca2+-ATPase (IC50 = 127 mu M). In the membrane preparation of the LLC-PKI cells stably expressing rabbit gastric H+,K+-ATPase, DIOA inhibited activities of the endogenous Na+,K+-ATPase (IC50=95 mu M) and the exogenous H+,K+-ATPase (IC50=75 mu M). 5-Nitro-2(3-phenylpropylamino)-benzoic acid (NPPB), a Cl- channel blocker, had no effects on the DIOA-elicited inhibition of the P-type ATPases. These findings suggest that lower concentration of DIOA (< 20-30 mu M) should be used for evaluation of the activity of K+-Cl- cotransporter without affecting the activities of coexisting Na+,K+-ATPase and/or H+,K+-ATPase in cells. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:123 / 126
页数:4
相关论文
共 16 条
[1]   Regulation of K-Cl cotransport: from function to genes [J].
Adragna, NC ;
Di Fulvio, M ;
Lauf, PK .
JOURNAL OF MEMBRANE BIOLOGY, 2004, 201 (03) :109-137
[2]   Structure-function relationship in P-type ATPases-a biophysical approach [J].
Apell, H. -J. .
REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 150, 2004, 150 :1-35
[3]   Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function [J].
Blanco, G ;
Mercer, RW .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 275 (05) :F633-F650
[4]  
GARAY RP, 1988, MOL PHARMACOL, V33, P696
[5]  
GARAY RP, 1986, N-S ARCH PHARMACOL, V334, P201
[6]   [(Dihydroindenyl) oxy]alkaonic acid inhibits the cystic fibrosis transmembrane conductance regulator [J].
Ito, Y ;
Aoyama, M ;
Yamada, N ;
Mizuno, Y ;
Kume, H ;
Yamaki, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 426 (03) :175-178
[7]   Stable expression of gastric proton pump activity at the cell surface [J].
Kimura, T ;
Yoshida, A ;
Tabuchi, Y ;
Ikari, A ;
Takeguchi, N ;
Asano, S .
JOURNAL OF BIOCHEMISTRY, 2002, 131 (06) :923-932
[8]   K-CI cotransport: Properties and molecular mechanism [J].
Lauf, PK ;
Adragna, NC .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2000, 10 (5-6) :341-354
[9]  
Linton SM, 1999, J EXP BIOL, V202, P1561
[10]  
MORII M, 1986, J BIOL CHEM, V261, P2343